Form 8-K - Current report:
SEC Accession No. 0001104659-23-071175
Filing Date
2023-06-14
Accepted
2023-06-14 16:00:46
Documents
13
Period of Report
2023-06-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2318475d1_8-k.htm   iXBRL 8-K 28976
2 EXHIBIT 3.1 tm2318475d1_ex3-1.htm EX-3.1 3917
  Complete submission text file 0001104659-23-071175.txt   210216

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA asrt-20230612.xsd EX-101.SCH 3039
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE asrt-20230612_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asrt-20230612_pre.xml EX-101.PRE 22599
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2318475d1_8-k_htm.xml XML 3716
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39294 | Film No.: 231014060
SIC: 2834 Pharmaceutical Preparations